{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:44:56Z","timestamp":1787791496085,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2024-4-2048"],"award-info":[{"award-number":["2024-4-2048"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2022YFE0112500"],"award-info":[{"award-number":["2022YFE0112500"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["62027813"],"award-info":[{"award-number":["62027813"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Hospitals Authority Clinical medicine Development of special funding support","doi-asserted-by":"crossref","award":["YGLX202518"],"award-info":[{"award-number":["YGLX202518"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03739-z","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:59:34Z","timestamp":1754643574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bibliometric analysis of publication trends in meningioma research (1992\u2009\u2212\u20092023)"],"prefix":"10.1007","volume":"48","author":[{"given":"Xulei","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiWei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"3739_CR1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2011\u20132015. Neuro Oncol 20:iv1\u2013iv86","journal-title":"Neuro Oncol"},{"key":"3739_CR2","doi-asserted-by":"crossref","DOI":"10.21037\/cco.2017.05.02","volume":"6","author":"PN Harter","year":"2017","unstructured":"Harter PN, Braun Y, Plate KH (2017) Classification of meningiomas-advances and controversies. Chin Clin Oncol 6:S2","journal-title":"Chin Clin Oncol"},{"key":"3739_CR3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.wneu.2014.12.015","volume":"83","author":"HJ Westwick","year":"2015","unstructured":"Westwick HJ, Yuh SJ, Shamji MF (2015) Complication avoidance in the resection of spinal meningiomas. World Neurosurg 83:627\u2013634","journal-title":"World Neurosurg"},{"key":"3739_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99:307\u2013314","journal-title":"J Neurooncol"},{"key":"3739_CR5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/aje\/kwj254","volume":"164","author":"A Wigertz","year":"2006","unstructured":"Wigertz A, Lonn S, Mathiesen T et al (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629\u2013636","journal-title":"Am J Epidemiol"},{"key":"3739_CR6","doi-asserted-by":"crossref","unstructured":"Park H, Lee IS, Lee H, Chae Y (2020) Bibliometric analysis of moxibustion research trends over the past 20 years. J Clin Med 9","DOI":"10.3390\/jcm9051254"},{"key":"3739_CR7","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/1008-682X.171582","volume":"18","author":"A Agarwal","year":"2016","unstructured":"Agarwal A, Durairajanayagam D, Tatagari S et al (2016) Bibliometrics: tracking research impact by selecting the appropriate metrics. Asian J Androl 18:296\u2013309","journal-title":"Asian J Androl"},{"key":"3739_CR8","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.683389","volume":"8","author":"C Corley","year":"2021","unstructured":"Corley C, Allen AR (2021) A bibliometric analysis of cyclophosphamide, methotrexate, and fluorouracil breast cancer treatments: implication for the role of inflammation in cognitive dysfunction. Front Mol Biosci 8:683389","journal-title":"Front Mol Biosci"},{"key":"3739_CR9","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00381-019-04254-5","volume":"35","author":"VM Lu","year":"2019","unstructured":"Lu VM, Power EA, Kerezoudis P, Daniels DJ (2019) The 100 most-cited articles about diffuse intrinsic pontine glioma: a bibliometric analysis. Childs Nerv Syst 35:2339\u20132346","journal-title":"Childs Nerv Syst"},{"key":"3739_CR10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.scitotenv.2012.11.061","volume":"443","author":"HZ Fu","year":"2013","unstructured":"Fu HZ, Wang MH, Ho YS (2013) Mapping of drinking water research: a bibliometric analysis of research output during 1992\u20132011. Sci Total Environ 443:757\u2013765","journal-title":"Sci Total Environ"},{"key":"3739_CR11","doi-asserted-by":"crossref","unstructured":"Ferro M, Lucarelli G, de Cobelli O et al (2021) The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncology. Minerva Urol Nephrol","DOI":"10.23736\/S2724-6051.21.04098-4"},{"key":"3739_CR12","first-page":"1752","volume":"7","author":"Y Yan","year":"2012","unstructured":"Yan Y, Guo Z, Zhang H, Wang N, Xu Y (2012) Precision radiotherapy for brain tumors: a 10-year bibliometric analysis. Neural Regen Res 7:1752\u20131759","journal-title":"Neural Regen Res"},{"key":"3739_CR13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00381-020-04863-5","volume":"37","author":"RG Siada","year":"2021","unstructured":"Siada RG, Lu VM, Daniels DJ (2021) Understanding the trajectory of research efforts in atypical teratoid rhabdoid tumors: a bibliometric analysis of the 50 most impactful studies to date. Childs Nerv Syst 37:419\u2013425","journal-title":"Childs Nerv Syst"},{"key":"3739_CR14","doi-asserted-by":"crossref","first-page":"16569","DOI":"10.1073\/pnas.0507655102","volume":"102","author":"JE Hirsch","year":"2005","unstructured":"Hirsch JE (2005) An index to quantify an individual\u2019s scientific research output. Proc Natl Acad Sci U S A 102:16569\u201316572","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3739_CR15","doi-asserted-by":"crossref","first-page":"1074003","DOI":"10.3389\/fmicb.2022.1074003","volume":"13","author":"R Huang","year":"2022","unstructured":"Huang R, Zhang M, Lu Y et al (2022) Effects of intestinal microbes on rheumatic diseases: A bibliometric analysis. Front Microbiol 13:1074003","journal-title":"Front Microbiol"},{"key":"3739_CR16","volume":"10","author":"CM Sharma","year":"2024","unstructured":"Sharma CM, Chariar VM (2024) Diagnosis of mental disorders using machine learning: literature review and bibliometric mapping from 2012 to 2023. Heliyon 10:e32548","journal-title":"Heliyon"},{"key":"3739_CR17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuchi.2025.101632","volume":"71","author":"H Baric","year":"2025","unstructured":"Baric H, Komljenovic S, Garcia SG, Niemela M (2025) Skull base meningiomas: a bibliometric analysis and comprehensive overview of clinical reports. Neurochirurgie 71:101632","journal-title":"Neurochirurgie"},{"key":"3739_CR18","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/j.wneu.2019.03.104","volume":"127","author":"XJ Ma","year":"2019","unstructured":"Ma XJ, Zhang GJ, Wang W, Li D, Wu Z, Zhang JT (2019) Proposed treatment for intracranial transitional meningioma: a single-center series of 298 cases. World Neurosurg 127:e280\u2013e287","journal-title":"World Neurosurg"},{"key":"3739_CR19","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Song LR, Huo XL et al (2020) Microrna-221\/222 inhibits the radiation-induced invasiveness and promotes the radiosensitivity of malignant meningioma cells. Front Oncol 10:1441","journal-title":"Front Oncol"},{"key":"3739_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4103\/0028-3886.227310","volume":"66","author":"W Liu","year":"2018","unstructured":"Liu W, Tang J, Wu Z, Zhang J (2018) An unusual presentation of intracranial meningioma in Hajdu-Cheney syndrome. Neurol India 66:566\u2013568","journal-title":"Neurol India"},{"key":"3739_CR21","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.wneu.2019.12.182","volume":"136","author":"LR Song","year":"2020","unstructured":"Song LR, Li D, Weng JC et al (2020) MicroRNA-195 functions as a tumor suppressor by directly targeting fatty acid synthase in malignant meningioma. World Neurosurg 136:e355\u2013e364","journal-title":"World Neurosurg"},{"key":"3739_CR22","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"3739_CR23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, Stavrinou P, Jenkinson MD et al (2021) EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol 23:1821\u20131834","journal-title":"Neuro Oncol"},{"key":"3739_CR24","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2008.08.058","volume":"74","author":"TF DeLaney","year":"2009","unstructured":"DeLaney TF, Liebsch NJ, Pedlow FX et al (2009) Phase II study of high-dose photon\/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 74:732\u2013739","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3739_CR25","volume":"103","author":"SK Kose","year":"2024","unstructured":"Kose SK, Aydogdu G, Demir E, Kiraz M (2024) Looking backward toward the future: a bibliometric analysis of the last 40 years of meningioma global outcomes. Med Baltim 103:e39241","journal-title":"Med Baltim"},{"key":"3739_CR26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/lio2.643","volume":"6","author":"DB Welling","year":"2021","unstructured":"Welling DB, Collier KA, Burns SS et al (2021) Early phase clinical studies of AR-42, a histone deacetylase inhibitor, for neurofibromatosis type 2-associated vestibular schwannomas and meningiomas. Laryngoscope Investig Otolaryngol 6:1008\u20131019","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"3739_CR27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/1078-0432.CCR-19-2109","volume":"26","author":"T Graillon","year":"2020","unstructured":"Graillon T, Sanson M, Campello C et al (2020) Everolimus and octreotide for patients with recurrent meningioma: results from the phase II cevorem trial. Clin Cancer Res 26:552\u2013557","journal-title":"Clin Cancer Res"},{"key":"3739_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11060-016-2172-3","volume":"129","author":"KC Shih","year":"2016","unstructured":"Shih KC, Chowdhary S, Rosenblatt P et al (2016) A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma. J Neurooncol 129:281\u2013288","journal-title":"J Neurooncol"},{"key":"3739_CR29","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1158\/1535-7163.MCT-21-0143","volume":"20","author":"MA Karajannis","year":"2021","unstructured":"Karajannis MA, Mauguen A, Maloku E et al (2021) Phase 0 clinical trial of everolimus in patients with vestibular schwannoma or meningioma. Mol Cancer Ther 20:1584\u20131591","journal-title":"Mol Cancer Ther"},{"key":"3739_CR30","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1200\/JCO.2015.61.6490","volume":"33","author":"Y Ji","year":"2015","unstructured":"Ji Y, Rankin C, Grunberg S et al (2015) Double-blind phase III randomized trial of the antiprogestin agent mifepristone in the treatment of unresectable meningioma: SWOG S9005. J Clin Oncol 33:4093\u20134098","journal-title":"J Clin Oncol"},{"key":"3739_CR31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/neuonc\/noab243","volume":"24","author":"M Preusser","year":"2022","unstructured":"Preusser M, Silvani A, Le Rhun E et al (2022) Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase II study of the EORTC brain tumor group (EORTC-1320-BTG). Neuro Oncol 24:755\u2013767","journal-title":"Neuro Oncol"},{"key":"3739_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/neuonc\/noab118","volume":"24","author":"WL Bi","year":"2022","unstructured":"Bi WL, Nayak L, Meredith DM et al (2022) Activity of PD-1 blockade with nivolumab among patients with recurrent atypical\/anaplastic meningioma: phase II trial results. Neuro Oncol 24:101\u2013113","journal-title":"Neuro Oncol"},{"key":"3739_CR33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-011-0687-1","volume":"106","author":"DA Reardon","year":"2012","unstructured":"Reardon DA, Norden AD, Desjardins A et al (2012) Phase II study of Gleevec(R) plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J Neurooncol 106:409\u2013415","journal-title":"J Neurooncol"},{"key":"3739_CR34","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","volume":"16","author":"S Goutagny","year":"2010","unstructured":"Goutagny S, Yang HW, Zucman-Rossi J et al (2010) Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res 16:4155\u20134164","journal-title":"Clin Cancer Res"},{"key":"3739_CR35","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/neuonc\/noab114","volume":"23","author":"Z Bao","year":"2021","unstructured":"Bao Z, Hua L, Ye Y et al (2021) MEF2C silencing downregulates NF2 and E-cadherin and enhances Erastin-induced ferroptosis in meningioma. Neuro Oncol 23:2014\u20132027","journal-title":"Neuro Oncol"},{"key":"3739_CR36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12964-017-0189-7","volume":"15","author":"Y Mei","year":"2017","unstructured":"Mei Y, Du Z, Hu C et al (2017) Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal 15:34","journal-title":"Cell Commun Signal"},{"key":"3739_CR37","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/onc.2012.436","volume":"32","author":"M Peyre","year":"2013","unstructured":"Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E et al (2013) Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Oncogene 32:4264\u20134272","journal-title":"Oncogene"},{"key":"3739_CR38","first-page":"vdz055","volume":"2","author":"J Deng","year":"2020","unstructured":"Deng J, Hua L, Han T et al (2020) The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations. Neurooncol Adv 2:vdz055","journal-title":"Neurooncol Adv"},{"key":"3739_CR39","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3171\/2017.2.JNS162566","volume":"128","author":"L Hua","year":"2018","unstructured":"Hua L, Zhu H, Li J et al (2018) Prognostic value of estrogen receptor in WHO grade III meningioma: a long-term follow-up study from a single institution. J Neurosurg 128:1698\u20131706","journal-title":"J Neurosurg"},{"key":"3739_CR40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1158\/0008-5472.CAN-07-1796","volume":"68","author":"EB Claus","year":"2008","unstructured":"Claus EB, Park PJ, Carroll R, Chan J, Black PM (2008) Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314\u2013322","journal-title":"Cancer Res"},{"key":"3739_CR41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-009-0086-z","volume":"98","author":"P Guevara","year":"2010","unstructured":"Guevara P, Escobar-Arriaga E, Saavedra-Perez D et al (2010) Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. J Neurooncol 98:379\u2013384","journal-title":"J Neurooncol"},{"key":"3739_CR42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3109\/02688697.2010.522743","volume":"25","author":"E Abdelzaher","year":"2011","unstructured":"Abdelzaher E, El-Gendi SM, Yehya A, Gowil AG (2011) Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression. Br J Neurosurg 25:707\u2013713","journal-title":"Br J Neurosurg"},{"key":"3739_CR43","volume":"10","author":"LW Zhong","year":"2024","unstructured":"Zhong LW, Chen KS, Yang HB, Liu SD, Zong ZT, Zhang XQ (2024) Exploring machine learning applications in meningioma research (2004\u20132023). Heliyon 10:e32596","journal-title":"Heliyon"},{"key":"3739_CR44","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/02688697.2022.2034745","volume":"37","author":"A Patel","year":"2023","unstructured":"Patel A, Abdelsalam A, Shariff RK et al (2023) Bibliometric analysis of the top 100 cited articles on stereotactic radiosurgery of intracranial meningiomas. Br J Neurosurg 37:1088\u20131093","journal-title":"Br J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03739-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:13:53Z","timestamp":1772079233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3739"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03739-z","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there was no any interest for any person or organization.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This prospective observation study was approved by institutional Ethics Committee and the informed consents were achieved by the patients or the legal guardians. All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"595"}}